Updated results on genomically tailored therapy for lung cancer patients
Selpercatinib was granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration in 2018…
Browsing: Breakthrough Therapy Designation
Selpercatinib was granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration in 2018…